Sanofi India appointed Mr. Rahul Bhatnagar as Chairman of its Board of Directors effective 30th April 2026.
Mr. Bhatnagar succeeds Mr. Aditya Narayan, who completed a ten-year tenure as Independent Director.
Independent Director Mrs. Usha Thorat's tenure ended on 29th April 2026, with the Board expressing appreciation.
The press release outlines Sanofi's seven-decade presence in India, including manufacturing, clinical trials, and charitable programs.